市場調査レポート
商品コード
1064654
アフィニトール薬の世界市場(2021年~2027年)Global Afinitor Drug Market 2021-2027 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
アフィニトール薬の世界市場(2021年~2027年) |
出版日: 2022年01月27日
発行: Orion Market Research
ページ情報: 英文 85 Pages
納期: 2~3営業日
|
世界のアフィニトール薬の市場規模は、予測期間中にかなりのCAGRで成長すると予測されています。当市場を牽引する主な要因には、臓器移植の数のかなりの増加と癌などの慢性疾患の発生率の上昇などがあります。
当レポートではアフィニトール薬市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、タイプ別、用途別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。
Global Afinitor Drug Market Size, Share & Trends Analysis Report By Type (2.5 Mg, 5 Mg, 7 Mg, and 10 Mg), By Application (Hospitals, Drug Stores, Others), Forecast (2021 - 2027)
The global afinitor drug market is anticipated to grow at a considerable CAGR during the forecast period. The considerable increase in the number of organ transplants and rising incidences of chronic diseases such as cancer are some key creating demand for the afinitor drug market. According to the US Health Resources and Services Administration, in 2020, nearly 39,000 organ transplants were performed in the US.
The global afinitor drug market is segmented based on type and application. Based on type, the afinitor drug market is segmented into 2.5 Mg, 5 Mg, 7 Mg, and 10 Mg. Based on application, the afinitor drug market is segmented into hospitals, drug stores, and others.
Geographically, the global afinitor drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global afinitor drug market include Novartis International AG, Teva Pharmaceuticals Industries Ltd., and more.
Market Segmentation
The Report Covers